We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Linkage Analysis Shows Susceptibility to Cold Sores Is Inherited

By Labmedica staff writers
Posted on 18 Feb 2008
There is a high probability that people who are prone to herpes simplex virus (HSV) outbreaks can inherit that susceptibility through their genes.

Scientists have identified a region on the long arm of human chromosome 21 with high odds of being linked to cold sore susceptibility. More...
Six specific genes were pinpointed in that chromosomal region as candidates for making people prone to outbreaks of cold sores (also called "fever blisters”). Cold sores occur when the herpes virus reactivates from its quiescent state within the nerve, infecting the lip, nose, or face.

Herpes simplex virus type 1 (HSV-1) is responsible for the vast majority of cold sores, the most common recurring viral infection in humans, as well as herpes keratits, an eye infection that can lead to corneal scarring and blindness. The majority of the U.S. population is infected with HSV-1, although millions of people manifest no symptoms. Nonetheless, at least 40% of the population will experience at least one cold sore at some point during their lives.

To search for cold sore susceptibility genes, University of Utah (Salt Lake City, UT, USA) investigators used linkage analysis, which traces genetic markers in families to identify regions on chromosomes that harbor disease genes. When genetic mutations are passed from parent to offspring, genetic markers near the disease gene are passed along as well. By identifying markers shared among family members, scientists can locate regions of chromosomes where genes responsible for disease may lie. The study was the first whole-genome study of HSV to use linkage analysis.

Four hundred and twenty-one people from 39 large Utah families were studied. The families are part of a genomic study called the Utah Genetic Reference Project. Participants were grouped according to how often they experienced cold sore outbreaks: frequently affected--at least two or more outbreaks of HSV-1 annually; mildly affected--two or less outbreaks annually; unaffected--HSV-1 infected but had never experienced an outbreak; and unknown or HSV uninfected--not categorized.

The uncategorized and mildly affected groups were excluded from the study. When all the genetics data were collected, a mathematical analysis determined the odds of a link between cold sores and the long arm of chromosome 21 to be at least 1,000-to-1. The probable genetic link is not the only component believed to trigger reactivation of HSV and cold sores. Environmental factors, such as fever, wind, and sunburn, as well as viral factors, such as strain and burden of latent infection, also influence the frequency of HSV outbreaks. Discovery of the probable link could lead to the development of new drugs that reduce the frequency of herpes outbreaks.

The study was reported in the February 1, 2008, issue of The Journal of Infectious Diseases and is available online.


Related Links:
University of Utah

Platinum Member
Xylazine Immunoassay Test
Xylazine ELISA
Verification Panels for Assay Development & QC
Seroconversion Panels
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
hCG Whole Blood Pregnancy Test
VEDALAB hCG-CHECK-1
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.